WallStSmart
EQ

Equillium Inc

NASDAQ: EQ · HEALTHCARE · BIOTECHNOLOGY

$2.08
+1.46% today

Updated 2026-04-29

Market cap
$136.57M
P/E ratio
P/S ratio
20.22x
EPS (TTM)
$-0.39
Dividend yield
52W range
$0 – $3
Volume
0.5M

Equillium Inc (EQ) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$15.76M$36.08M$41.09M$130000.00
Revenue growth (YoY)+129.0%+13.9%-99.7%
Cost of revenue$122.00$6102.00$23000.00$45000.00$72000.00$118000.00$126000.00$137000.00$65000.00
Gross profit$-122.00$-6102.00$-23000.00$-45000.00$-72000.00$15.76M$36.08M$41.09M$65000.00
Gross margin100.0%100.0%100.0%50.0%
R&D$1.33M$4.94M$17.64M$19.38M$26.38M$37.55M$37.04M$37.43M$12.84M
SG&A$378330.00$3.67M$9.09M$10.16M$11.41M$17.24M$13.57M$11.94M$10.79M
Operating income$-1.71M$-8.62M$-26.73M$-29.55M$-37.79M$-62.08M$-14.52M$-8.27M$-23.63M
Operating margin-393.9%-40.2%-20.1%-18180.0%
EBITDA$-1.88M$-8.61M$-26.70M$-29.50M$-37.71M$-61.26M$-12.14M$-7.57M$-23.52M
EBITDA margin-388.7%-33.6%-18.4%-18090.8%
EBIT$-1.88M$-8.62M$-26.73M$-29.55M$-37.79M$-61.38M$-12.26M$-7.71M$-23.63M
Interest expense$379385.00$2.56M$279000.00$1.10M$1.07M$1.05M$491000.00$0.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-2.26M$-13.25M$-25.58M$-29.77M$-38.98M$-62.43M$-13.34M$-8.07M$-22.40M
Net income growth (YoY)-485.8%-93.0%-16.4%-30.9%-60.2%+78.6%+39.5%-177.6%
Profit margin-396.1%-37.0%-19.6%-17229.2%